‘Significant’ racial, ethnic disparities exist in curative treatment for early-stage HCC

WASHINGTON — Fewer Black and Hispanic patients received curative treatment for early-stage hepatocellular carcinoma compared with white patients, according to research presented at The Liver Meeting.“HCC is the third leading cause of cancer-related death worldwide. Prognosis varies significantly based on stage of diagnosis. Unfortunately, HCC is usually detected at a later stage when treatment options are limited, and prognosis is poor. However, curative treatments are available for patients detected at an early stage, and these include surgical resection, local ablation and liverRead More

Generated by Feedzy